New hope pill tested for lymphoma that Won't quit
NCT ID NCT04842877
Summary
This study is testing an experimental daily pill called valemetostat for adults whose B-cell lymphoma has returned or hasn't responded to standard treatments. The main goal is to see how well the drug shrinks tumors and how safe it is for patients who have few other options. About 141 people with different types of B-cell lymphoma will take the pill daily to see if it can control their cancer.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LYMPHOMA, B-CELL are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
A.Z. Sint Jan AV
Bruges, 8000, Belgium
-
CH Tourelle Peltzer
Verviers, 4800, Belgium
-
CH d'Avignon
Avignon, 84000, France
-
CH de la Côte Basque
Bayonne, 64109, France
-
CHU Hôtel Dieu
Nantes, 44093, France
-
CHU Mont-Godinne
Yvoir, Belgium
-
CHU Pontchaillou
Rennes, 35003, France
-
CHU d'Estaing
Clermont-Ferrand, 63000, France
-
CHU de Dijon
Dijon, 21034, France
-
CHU de Montpellier
Montpellier, 34295, France
-
Ch Metropole Savoie - Site Chambery
Chambéry, 73000, France
-
Ch de Bretagne Atlantique -
Vannes, 56017, France
-
Chd de Vendee
La Roche-sur-Yon, 85925, France
-
Clinique Victor Hugo
Le Mans, 72000, France
-
Emmanuel Bachy
Pierre-Bénite, 69495, France
-
François Lemonnier
Créteil, 94010, France
-
Gh Region Mulhouse Et Sud Alsace
Mulhouse, 68070, France
-
Institut Bergonié
Bordeaux, 33076, France
-
Institut Paoli Calmette
Marseille, 13273, France
-
Institut d'Hématologie de Basse Normandie
Caen, 14076, France
-
Service des Maladies du Sang - CHRU de Lille
Lille, 59037, France
-
University Hospital Gent
Ghent, 9000, Belgium
Conditions
Explore the condition pages connected to this study.